Crossref
Long-term safety of botulinum toxin in a patient of myasthenia gravis with hemifacial spasm
Annals of Movement Disorders · 2025
DOI: 10.4103/aomd.aomd_109_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Movement Disorders, 2025. Verfasst von Kshitij Bansal und 4 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bansal, K., Chawla, T., Goyal, C., Elavarasi, A., & Goyal, V. (2025). Long-term safety of botulinum toxin in a patient of myasthenia gravis with hemifacial spasm. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_109_24
Vancouver
Bansal K, Chawla T, Goyal C, Elavarasi A, Goyal V. Long-term safety of botulinum toxin in a patient of myasthenia gravis with hemifacial spasm. Annals of Movement Disorders. 2025. doi:10.4103/aomd.aomd_109_24
BibTeX
@article{Bansal2025,
author = {Bansal, Kshitij and Chawla, Tanushree and Goyal, Chanchal and Elavarasi, Arunmozhimaran and Goyal, Vinay},
title = {Long-term safety of botulinum toxin in a patient of myasthenia gravis with hemifacial spasm},
journal = {Annals of Movement Disorders},
year = {2025},
doi = {10.4103/aomd.aomd_109_24}
}
EUVIMED